These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19068015)

  • 21. Switching depot antipsychotic drug responders to oral olanzapine.
    Godleski LS; Goldsmith LJ; Vieweg WV; Zettwoch N; Stikovac D; Lewis S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):141-4. PubMed ID: 15610956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
    Simpson GM; Weiden P; Pigott T; Murray S; Siu CO; Romano SJ
    Am J Psychiatry; 2005 Aug; 162(8):1535-8. PubMed ID: 16055779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
    Hofer A; Rettenbacher MA; Edlinger M; Huber R; Bodner T; Kemmler G; Sachs G; Fleischhacker WW
    Pharmacopsychiatry; 2007 Jan; 40(1):1-8. PubMed ID: 17327953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.
    Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with atypical antipsychotics and risk of weight gain.
    Stip E; Anselmo K; Wolfe M; Lessard C; Landry P
    Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
    Baptista T; Martinez M; Lacruz A; Arellano A; Mendoza S; Beaulieu S; Hernández L; Contreras Q; Galeazzi T; Vargas D
    Schizophr Res; 2007 Jan; 89(1-3):350-2. PubMed ID: 17029751
    [No Abstract]   [Full Text] [Related]  

  • 28. Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine".
    Reis de Sá A; Elkis H
    Braz J Psychiatry; 2007 Mar; 29(1):90; author reply 91. PubMed ID: 17435940
    [No Abstract]   [Full Text] [Related]  

  • 29. Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved.
    Koga M; Nakayama K
    Acta Psychiatr Scand; 2005 Jul; 112(1):75-6; discussion 77. PubMed ID: 15952949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
    Kinon BJ; Volavka J; Stauffer V; Edwards SE; Liu-Seifert H; Chen L; Adams DH; Lindenmayer JP; McEvoy JP; Buckley PF; Lieberman JA; Meltzer HY; Wilson DR; Citrome L
    J Clin Psychopharmacol; 2008 Aug; 28(4):392-400. PubMed ID: 18626265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
    Ascher-Svanum H; Stensland MD; Kinon BJ; Tollefson GD
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):110-7. PubMed ID: 16280344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine metabolic side effects: a weight gain issue?
    Carulli L; Mazzi F; Rondinella S; Bertolotti M
    Intern Emerg Med; 2008 Sep; 3(3):237-40. PubMed ID: 18369533
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.
    Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness criterion: balancing efficacy against the risks of weight gain.
    Citrome L
    J Clin Psychiatry; 2007; 68 Suppl 12():12-7. PubMed ID: 17956151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis.
    Wang J; Liu YS; Zhu WX; Zhang FQ; Zhou ZH
    Sci Rep; 2014 Dec; 4():7394. PubMed ID: 25487560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual suspect for antipsychotic-induced diabetes.
    O'Neill MF
    Drug Discov Today; 2005 Oct; 10(20):1338. PubMed ID: 16253867
    [No Abstract]   [Full Text] [Related]  

  • 37. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
    Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ
    J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.
    Bozina N; Medved V; Kuzman MR; Sain I; Sertic J
    J Psychopharmacol; 2007 Sep; 21(7):728-34. PubMed ID: 17092963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mifepristone treatment of olanzapine-induced weight gain in healthy men.
    Gross C; Blasey CM; Roe RL; Allen K; Block TS; Belanoff JK
    Adv Ther; 2009 Oct; 26(10):959-69. PubMed ID: 19888560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.